Advertisement
"Our earlier study with obese, type 2 diabetics demonstrated significantweight loss when adjusted for changes in diet." said FBCx co-inventor, Dr.Catherine Jen. "It's time to look at the non-obese population segment thatwould benefit from losing 10-25 pounds."
Advertisement
"We expect this study will show FBCx to be an easy and effective aid forlosing weight and for lowering elevated levels of blood fats," continued FBCxco-inventor, Dr. Joseph Artiss.
These findings and others have lead to FBCx being referred to as the"miracle weight loss" pill in media reports and by renowned members of themedical profession.
"We are so convinced of the efficacy of FBCx that we sought out and fundedthis major study ourselves," said Dr. Artiss.
"I have spent my entire career studying obesity. FBCx works where mostothers have failed to live up to their hype," stated Dr. Jen.
FBCx co-inventors are Associate Professor of Pathology Joseph Artiss,Ph.D., FACB and K-L Catherine Jen, Ph.D., Professor and Chair of Nutrition andFood Science, both of Wayne State University in Detroit, Michigan.
Six tablets daily are capable of removing 50-60% of the calories from atypical North American diet.Previous FBCx study findings include: -- Effective at reducing and/or maintaining body weight in patients with type 2 diabetes. -- Lowered both triglyceride and LDL (bad) cholesterol levels in patients who began the study with elevated triglyceride levels. -- Blood work findings indicate an insulin sensitivity increase and therefore a possible delay in the need to institute or the intensity of insulin therapy in type 2 diabetics. -- FBCx was shown to bind and remove 9 times its own weight in dietary fat, essentially preventing 80 calories from being absorbed per tablet. -- FBCx appears to preferentially bind saturated over unsaturated dietary fats. -- FBCx produced no adverse side effects.
SOURCE ArtJen Complexus Holdings Corp.
